Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Reviva Pharmaceuticals Beat Earnings?

Reviva Pharmaceuticals (RVPH) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Reviva Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full RVPH stock analysis or the earnings calendar for upcoming reports.

Reviva Pharmaceuticals Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue————————
Gross margin————————
Operating margin————————
Net income-8.4M-6.3M-6.4M-6.1M-4M-3.4M-3.2M-2,448B
Net margin————————
EPS————————

Reviva Pharmaceuticals Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Reviva Pharmaceuticals’s quarterly revenue moved from $0 to $0.

When Is Reviva Pharmaceuticals’s Next Earnings Date?

Reviva Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the RVPH earnings calendar.

Frequently Asked Questions: Reviva Pharmaceuticals Earnings

Reviva Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Reviva Pharmaceuticals reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the RVPH AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.